179 related articles for article (PubMed ID: 6804248)
1. Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig.
Chignard M; Wal F; Lefort J; Vargaftig BB
Eur J Pharmacol; 1982 Feb; 78(1):71-9. PubMed ID: 6804248
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological properties of PAF-acether in the guinea-pig: platelet-dependent and independent reactions.
Lefort J; Wal F; Chignard M; Medeiros MC; Vargaftig BB
Agents Actions; 1982 Dec; 12(5-6):723-5. PubMed ID: 7164948
[TBL] [Abstract][Full Text] [Related]
3. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
Lefort J; Rotilio D; Vargaftig BB
Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
[TBL] [Abstract][Full Text] [Related]
4. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs.
Coëffier E; Borrel MC; Lefort J; Chignard M; Broquet C; Heymans F; Godfroid JJ; Vargaftig BB
Eur J Pharmacol; 1986 Nov; 131(2-3):179-88. PubMed ID: 3816952
[TBL] [Abstract][Full Text] [Related]
5. Role of platelets in aspirin-sensitive bronchoconstriction in the guinea-pig; interactions with salicylic acid.
Lefort J; Vargaftig BB
Br J Pharmacol; 1978 May; 63(1):35-42. PubMed ID: 647162
[TBL] [Abstract][Full Text] [Related]
6. Bronchoconstriction induced by intratracheal administration of platelet-activating factor (PAF-acether) in baboons.
Denjean A; Arnoux B; Benveniste J; Lockhart A; Masse R
Agents Actions; 1981 Dec; 11(6-7):567-8. PubMed ID: 7340444
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drugs if combined with anti-histamine and anti-serotonin agents interfere with the bronchial and platelet effects of "platelet-activating factor" (PAF-acether).
Vargaftig BB; Lefort J; Wal F; Chignard M; Medeiros MC
Eur J Pharmacol; 1982 Aug; 82(3-4):121-30. PubMed ID: 7128682
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of 48740 R.P., a PAF-acether antagonist.
Lefort J; Sedivy P; Desquand S; Randon J; Coëffier E; Maridonneau-Parini I; Floch A; Benveniste J; Vargaftig BB
Eur J Pharmacol; 1988 Jun; 150(3):257-68. PubMed ID: 2843382
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs.
Lellouch-Tubiana A; Lefort J; Pirotzky E; Vargaftig BB; Pfister A
Br J Exp Pathol; 1985 Jun; 66(3):345-55. PubMed ID: 3890915
[TBL] [Abstract][Full Text] [Related]
12. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.
Desquand S; Touvay C; Randon J; Lagente V; Vilain B; Maridonneau-Parini I; Etienne A; Lefort J; Braquet P; Vargaftig BB
Eur J Pharmacol; 1986 Aug; 127(1-2):83-95. PubMed ID: 3019727
[TBL] [Abstract][Full Text] [Related]
13. Relaxation of the guinea-pig trachea induced by platelet-activating factor and by serotonin.
Prancan A; Lefort J; Barton M; Vargaftig BB
Eur J Pharmacol; 1982 May; 80(1):29-35. PubMed ID: 7095003
[TBL] [Abstract][Full Text] [Related]
14. The effect of sulphinpyrazone and its metabolites on platelet function in vitro and ex vivo.
Pay GF; Wallis RB; Zelaschi D
Haemostasis; 1981; 10(3):165-75. PubMed ID: 7262645
[TBL] [Abstract][Full Text] [Related]
15. Platelet-lung in vivo interactions: an artifact of a multi-purpose model?
Vargaftig BB; Lefort J; Prancan AV; Chignard M; Benveniste J
Haemostasis; 1979; 8(3-5):171-82. PubMed ID: 511008
[TBL] [Abstract][Full Text] [Related]
16. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
17. Suppression of PAF-induced bronchoconstriction in the guinea-pig by oxatomide: mechanism of action.
Nijkamp FP; Folkerts G; Beetens JR; De Clerck F
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):111-8. PubMed ID: 2571942
[TBL] [Abstract][Full Text] [Related]
18. Doxofylline exerts a prophylactic effect against bronchoconstriction and pleurisy induced by PAF.
Franzone JS; Cirillo R; Biffignandi P
Eur J Pharmacol; 1989 Jun; 165(2-3):269-77. PubMed ID: 2776832
[TBL] [Abstract][Full Text] [Related]
19. Effect of sulphinpyrazone on human platelet aggregation, 5-hydroxytryptamine release and adhesion ex vivo: comparison with naproxen.
Nunn B; James FJ
Br J Clin Pharmacol; 1980 Mar; 9(3):239-45. PubMed ID: 7362733
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade.
Boukili MA; Bureau M; Lagente V; Lefort J; Lellouch-Tubiana A; Malanchère E; Vargaftig BB
Br J Pharmacol; 1986 Oct; 89(2):349-59. PubMed ID: 3096407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
